Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.As of 25 May 2026, PHAARMASIA LTD. share price is ₹80.84. The stock opened at ₹80.50, compared to its previous close of ₹80.84. During today's trading session, PHAARMASIA LTD. share price moved in the range of ₹80.50 to ₹80.84, with an average price of ₹80.67 for the day. Looking at its last 52-week, the stock has touched a low of ₹80.50 and a high of ₹80.84.
The market capitalization of PHAARMASIA LTD. is ₹55 Crs, with a P/E ratio of 3.1 and a dividend yield of 0.00%.